TCL Archive “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor November 8, 2013
TCL Archive Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials September 8, 1978